Michael Bretthauer Editor

Hans-Olov Adami was appointed to a national professorship in cancer epidemiology in 1990 after seventeen years as a practicing surgeon. As Professor and Chair, he founded the Department of Medical Epidemiology and Biostatistics at the Karolinska Institutet in Stockholm. Between 1992 and 2017, he served in various academic roles, including adjunct, visiting, and tenured professorships at the Harvard School of Public Health, where he also chaired the Department of Epidemiology from 2007 to 2011. Since 2012, he has been affiliated with Oslo University. Adami served on the Nobel Committee and is an elected member of the Royal Society of Sciences in Uppsala, the Swedish Royal Academy of Sciences, the European Academy of Cancer Sciences, Academia Europaea, and Sigma Xi. Pagona Lagiou, MD, MSc, PhD is Professor and Chair at the Department of Hygiene, Epidemiology & Medical Statistics, School of Medicine, National & Kapodistrian University of Athens (NKUA), Greece and Adjunct Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. Dr. Lagiou has served as Foreign Adjunct Associate Professor of Epidemiology at the Karolinska Institutet, Sweden. Michael Bretthauer, MD, PhD is Professor of Medicine at the University of Oslo and Gastroenterologist at Oslo University Hospital. He is Associate Editor at Annals of Internal Medicine and chair of the Board for research, quality assurance and innovation of the Norwegian Medical Association. Dr. Bretthauer received his MD in 1996 a PhD in 2004. He is board-certified in internal medicine and gastroenterology. He is the co-founder of the Clinical Effectiveness Research Group at the University of Oslo and Oslo University Hospital. Dr. Rulla M. Tamimi is the Chief of the Division of Epidemiology in the Department of Population Health Sciences and Associate Director, Population Science in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. Her scientific program integrates genetics, circulating biomarkers, imaging, and pathology, significantly enhancing our understanding and prediction of different breast cancer subtypes. She has led and participated in several international committees related to cancer research. Lorelei Mucci is a Professor of Epidemiology and Head of Cancer Epidemiology and Prevention at the Harvard T.H. Chan School of Public Health. She also serves as Associate Director of Population Sciences for the National Cancer Institute-funded Harvard Cancer Consortium and as Strategic Director of Research Partnerships at the American Cancer Society. Her research integrates molecular and cancer epidemiology approaches across the cancer continuum. A major focus of her work is genitourinary cancers, including research on etiology, molecular subtypes, survivorship, and prognosis. Mucci is co-Principal Investigator of the Health Professionals Follow-up Study, a cancer epidemiology cohort of 50,000 men that has been ongoing for 40 years. In addition, she is founding co-Principal Investigator of IRONMAN, a global registry of 5,000 patients with advanced metastatic prostate cancer recruited from 15 countries.